The Cure of Type 1 Diabetes

Q. 1: What is Type 1 Diabetes?

Pancreas is an organ located inside the abdomen. This organ contains insulin-secreting cells. Insulin-producing cells regulate the utilization of dietary sugars by all cells in the body. In persons with Type 1 diabetes mellitus (T1DM), most of the insulin-producing cells are destroyed. This contributes to life-threatening medical emergencies such as diabetic coma, or complications of diabetes affecting eyesight resulting in blindness, kidney failure, heart failure, or amputation of legs due to blockage of circulation.

Q. 2: How it is treated currently? 

When blood sugar is not controlled it is treated with delivery of insulin either in the form of injection or in the form of an insulin pump to prevent coma, complications of diabetes, and death.

Q. 3: How big is the problem?  

About 1.9 million people in the US have Type 1 diabetes mellitus, with this number expected to rise to 5 million by the year 2050.

Q. 4: What are the advances in the Cure of Type 1 Diabetes?  

As no effective evidenced-based medicine is available yet, the only alternatives are a solid organ pancreas transplant or transplantation of insulin-producing cells harvested from a donated pancreas.

1. Islet transplantation (Transplantation of Insulin-producing cells)  in the US is experimental and available only at sites that have received an exemption from the US Food and Drug Administration (US FDA) for clinical research of islet transplantation in T1DM.
2. In 2001, the National Institute of Diabetes & Digestive & Kidney Diseases established the Collaborative Islet Transplant Registry (CITR) to compile data from all islet transplant programs in North America from 1999 to the present. From 2005 the Clinical Islet Transplant Consortium (www.CITIsletStudy.org) conducted studies designed to advance the field of islet transplantation.
3. For more information: Visit https://citregistry.org/content/reports-publications-presentations

Q. 5: What is the role of Endocrine Technology, LLC?

At our biotechnology company in Nassau County, NY, we have the best investigational drug with a human safety record for islet cell transplant tolerance. It is backed with preclinical proof of efficacy in Type 1 Diabetes. It is available for Technology Licensing / Collaborations / Molecule for Testing /Product Development and Consulting.

We are also proud HIPAA compliant as we adhere to the privacy rights of our clients and partners by securing their information through our electronic health records.

For more information about Endocrine Technology, LLC (ETCOVID-19.COM), a proud HIPAA compliant in New York, please don’t hesitate to contact us by visiting https://www.etcovid-19.com or calling 347-302-3107. You can also request a teleconsultation by emailing us at etbond@gmail.com.